Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Current and historic HIV-1 molecular epidemiology in paediatric and adult population from Kinshasa in the Democratic Republic of Congo

Abstract

HIV-1 diversity may impact monitoring and vaccine development. We describe the most recent data of HIV-1 variants and their temporal trends in the Democratic Republic of Congo (DRC) from 1976 to 2018 and in Kinshasa from 1983–2018. HIV-1 pol sequencing from dried blood collected in Kinshasa during 2016–2018 was done in 340 HIV-infected children/adolescents/adults to identify HIV-1 variants by phylogenetic reconstructions. Recombination events and transmission clusters were also analyzed. Variant distribution and genetic diversity were compared to historical available pol sequences from the DRC in Los Alamos Database (LANL). We characterized 165 HIV-1 pol variants circulating in Kinshasa (2016–2018) and compared them with 2641 LANL sequences from the DRC (1976–2012) and Kinshasa (1983–2008). During 2016–2018 the main subtypes were A (26.7%), G (9.7%) and C (7.3%). Recombinants accounted for a third of infections (12.7%/23.6% Circulant/Unique Recombinant Forms). We identified the first CRF47_BF reported in Africa and four transmission clusters. A significant increase of subtype A and sub-subtype F1 and a significant reduction of sub-subtype A1 and subtype D were observed in Kinshasa during 2016–2018 compared to variants circulating in the city from 1983 to 2008. We provide unique and updated information related to HIV-1 variants currently circulating in Kinshasa, reporting the temporal trends of subtypes/CRF/URF during 43 years in the DRC, and providing the most extensive data on children/adolescents.

Introduction

Several independent zoonotic transmission events from primates to humans around the beginning of the twentieth century1 in Central and West Africa gave rise to Acquired Immune Deficiency Syndrome (AIDS) in the human population, spreading quickly worldwide2,3. The HIV epidemic is the result of two types of viruses: HIV-1 and HIV-2, which are closely related to SIVptt and SIVsm respectively4,5. HIV-1 causes most HIV infections worldwide and has been divided into 4 groups (M, N, O and P)3,6,7,8, but the global HIV epidemic is related to group M, which has been subdivided into 10 subtypes (A-D, F–H, J-L)1,9,10, at least 100 Circulating Recombinant Forms (CRF)11 and uncountable Unique Recombinant Forms (URF). HIV-1 diversity occurred in the early steps in the human adaptation of SIVptt12.

Since HIV-1 variability can impact transmission, pathogenesis and disease progression13,14,15, HIV monitoring16,17, resistance pathways18, cognitive impairment19, and HIV vaccine development20, an accurate HIV-1 variant identification is needed21. It can enable a better understanding of global HIV expansion22,23 and to infer the evolutionary possibilities in the selection of new variants, such as the recently described subtype L10. HIV-1 molecular surveillance studies are globally important and of interest in any setting. However, it is more interesting to analyze HIV molecular diversity in an area with a high viral diversity, especially if the place is the origin of a HIV-1 pandemic, where the virus has been circulating for a longer period and new, more pathogenic or transmissible variants could have arised. HIV-1 pandemic originated in Central Africa24, specifically in the DRC, Kinshasa being the epicenter12, spreading to neighboring cities or countries25.

The most ancestral available HIV-1 sequences were recovered from Kinshasa in 1959 (ZR59, near the ancestral node of subtypes B and D)26, 1960 (DRC60, subtype A)1 and 1966, (DRC66, subtype C)27. Subtype B also emerged in Kinshasa and was introduced into the Caribbean region via Haiti around 1966 by human migration and later disseminated to other regions, such as the United States of America, Europe, Asia, Latin America, and Australia23.

Accordingly, Kinshasa is one of the most relevant places to carry out surveillance programs to increase the knowledge of HIV molecular epidemiology and viral evolution. In that context, our study presents the most recent data related to current circulating HIV-1 variants in pol in Kinshasa during the 2016–2018 period, identifying transmission clusters and updating the genetic diversity. In addition, we present a complete review of HIV-1 variant trends in the DRC over 43 years (1976–2018) after using all the historical pol sequences available in Los Alamos HIV Sequence Database (LANL) from samples collected in the DRC. We reclassified all HIV-1 variants after new phylogenetic analysis in all downloaded pol sequences, including the most recent subtype L and new CRF described in the last years. Later we studied the temporal trends of HIV-1 variants in the DRC and Kinshasa considering the sampling year of each sequence.

Results

Current update of HIV molecular epidemiology in the DRC

We obtained viral pol sequences (115 protease, PR, 139 retrotranscriptase, RT and 115 integrase, IN) from 165 (48.5%) of 340 HIV-infected children/adolescents (55, 33.3%) and adults (110, 66.7%) from two hospitals in Kinshasa (DRC) with dried blood specimens (DBS) collected during 2016–2018 (Table 1). Thus, our study was done in 165 patients with available pol sequence. The median age [IQR] at DBS collection for children and adults was 14.4 [11.4–16.8] and 43 [34–53.5] years old, respectively. Around 75% of subjects with available pol sequence were under antiretroviral treatment (ART) and 8 out of 10 presented more than 1000 HIV-1 RNA copies/ml at sampling (Table 1).

Table 1 Main characteristics of HIV-1 infected population from Kinshasa (DRC) with collected DBS in 2016–2018.

From the historical database, we recovered 5672 group M pol sequences without gaps or ambiguities available in LANL, 4090 of them being assigned to HIV-1 pure subtypes (300 A, 2476 B, 1133 C, 72 D, 48 F, 45 G, 7 H, 5 J, 1 K, 3 L) and 1582 circulating recombinants forms CRF_01 to CRF_99. As expected, most (99.4%) viral sequences from the 165 subjects were classified as HIV-1 non-B variants in pol coding region. Among them, 59.4% were 9 pure non-B subtypes, 36.4% recombinant forms (23.7% URFs and 12.7% CRFs) and 3.6% unique unclassificable (U) sequences. The most frequent HIV-1 variant was subtype A (26.7%), followed by subtypes G (9.7%) and C (7.3%) (Fig. 1 and Sup. Fig. 1). The most prevalent CRF were CRF45_cpx (2.4%), CRF02_AG (1.8%) and CRF27_cpx (1.8%) in our cohort. Interestingly, we identified for the first time the CRF47_BF variant in the DRC, infecting an 8 year-old child. Among recombinant forms, URF accounted for 65% of infections in our study cohort (2016–2018). These URF were in circulation in Kinshasa during 2016–2018. Recombination patterns in the analyzed pol fragments assigned to URF among the 39 subjects is described in Fig. 2. When specific HIV-1 variants were compared between age groups, adults presented a greater number of different CRF (11 variants) than children/adolescent group (2 CRF: CRF27_cpx and CRF47_BF). Althought the children/adolescent group presented less diversity, they had almost 3 times as many URF infections than adults (40% vs. 14.5%; p < 0.05). The rate of pure subypes was similar across both groups.

Figure 1
figure 1

Current molecular epidemiology characterization in our HIV-1 study cohort from Kinshasa (DRC) with collected DBS in 2016–2018. Percentages calculated considering new HIV-1 pol sequences recovered from DBS of 165 HIV-1 infected subjects from Kinshasa during 2016–2018.

Figure 2
figure 2

Recombination structure of the available pol sequences assigned to URF and recovered from 39 HIV-1 infected subjects in Kinshasa (2016–2018). This figure represents a simplified URF structure. In bold, viruses collected from adults. The remaining, viruses collected from children/adolescents.

Cluster identification between non-epidemiologically related adults and children/adolescents

Among the 165 pol sequences from Kinshasa we identified 4 independent transmission clusters (Table 2 and Sup. Fig. 25) supported by 100% bootstrap, presenting recent transmission (genetic distance lower than 0.01) in three of them: cluster 1, cluster 3 and cluster 4. Infected individuals from clusters 1, 2 and 3 carried subtype A pol sequences, although they were not ascribed to previously characterized sub-subtypes A or CRF including A at pol coding region. They appeared in 3 different branches in PhyML trees after including all LANL sequences ascribed to subtype A and their sub-subtypes circulating in the DRC since 1976 (Sup. Fig. 24). Subjects from cluster 4 harbored subtype H viruses, clustering apart from other subtype H LANL sequences from the DRC (Sup. Fig. 5). Table 2 shows the epidemiological data collected from clinical reports of each patient. All clusters included 2 subjects, except cluster 1 including a 34.7 year-old woman, a 6.2 year-old boy and a 14.3 year-old adolescent male with no reported epidemiological link (Sup. Fig. 2). Clusters 2 and 3 included two adults and cluster 4 two children.

Table 2 Clusters identification in the studied population from Kinshasa in the 2016–2018 period.

Transmission networks involved a common recombinant fragment in recent paediatric/adolescents sequences from Kinshasa

Among the 165 new sequences (2016–2018), we found the presence of a transmission network, including two different clusters (RecG and RecB) of 17 viruses sharing one pol fragment (Table 3 and Sup. Fig. 6). Interestingly, all viruses involved were collected from paediatric patients with no epidemiological linkage according to clinical reports. Cluster RecB included viruses sharing a fragment of 599 nt in RT (positions 2935–3534 in HXB2) assigned to subtype B, in 8 patients ranging from 9 to 18 years-old. Cluster RecG included viruses from 9 adolescents from 10 to 19 years-old sharing a fragment in IN (positions 4390–5005 in HXB2) of 615 nt assigned to subtype G (Table 3). Of note, one pol sequence from a 19 year-old female (18.RDC_P83) shared fragments of both clusters (Sup. Fig. 6). The common progenitor viruses for clusters RecG and RecB using PhyML trees were not found in all 2802 LANL sequences from the DRC. We also observed a recombination event at protease coding region involving viruses from 2 adults (subtype A, CUN131 and subtype H, CUN127), leading to URF_A virus infecting CUN123 (Sup. Fig. 7).

Table 3 Description of recombination transmission net found among the 165 HIV-1 variants collected in Kinshasa from 2016 to 2018.

Reclassification of HIV-1 variants with LANL sequence circulating in the DRC since 1976

In order to increase the number of pol sequences from the DRC, we downloaded all 2802 available pol sequences in LANL, which had been collected since 1976 to 2012, mainly (99.9%) from adults (Fig. 3). Then, since new HIV-1 variants have appeared in the recent years, we reclassified the 2641 pure subtypes and CRF, excluding 161 URF, performing the same PhyML analysis and reference sequences set in the historic LANL database from the DRC as in our sequences collected in Kinshasa from 2016–2018. Interestingly, we found some discrepancies in the HIV-1 variant classification in 8.8% (198 sub-subtype A1 and 34 U) of them, which had probably been misclassified due to less available reference HIV-1 sequences and to the absence of new subtypes and new CRF when they were classified. The new PhyML analysis revealed that 198 (32.9%) of the 602 sequences originaly appointed as sub-subtype A1 in LANL were, in fact, other HIV-1 variants, 101 being subtype A (51%), 88 CRF02_AG (44.4%), 3 CRF11_cpx (1.5%), 3 CRF25_cpx (1.5%), 1 sub-subtype A6 (0.5%), 1 sub-subtype F1 (0.5%) and 1 U (0.5%). Among the 34 (26.6%) of 128 U LANL sequences from the DRC, 12 turned out to be subtype A (35.3%), 4 sub-subtype F1 (11.8%), 3 sub-subtype A4 (8.8%), 3 sub-subtype A5 (8.8%), 3 subtype D (8.8%), 3 CRF18_cpx (8.8%), 2 subtype K (5.9%), 1 CRF02_AG (2.9%), 1 subtype G (2.9%), 1 subtype H (2.9%), and 1 (0.5%) subtype L. Thus, one third (32.9%) of sub-subtype A1 and a quarter (26.6%) of U LANL sequences from the DRC had been previously misclassified.

Figure 3
figure 3

Comparison of HIV-1 variants in the study cohort (2016–2018) versus LANL sequences from the DRC (1976–2012) and Kinshasa (1983–2008). (A) Comparison of HIV-1 variants in the study cohort from Kinshasa (2016–2018) versus DRC sequences available in LANL (1976–2012). (B) Comparison of data between study cohort and LANL. (C) Evolution of pure subtypes and recombinants forms in the DRC by periods of time during 1983–2018. Panel C excludes pol sequences from the DRC sampled during 1977–1982, 1986, 1995, 2009, 2010, 2013–2015, due to their absence in LANL database. We clustered all sequences sampled during 1983–1994 as an “early period” to avoid biases due to the non-representative number of pol sequences each year within that period. Panels B and C exclude 214 LANL sequences from the DRC with unknown sampling time collected before 2012. (D) Comparison of HIV-1 variants distribution circulating in Kinshasa during 1983–2008 versus 2016–2018. For analysis we used the 181 pol sequences with available GenBank accession number from samples collected in that city during 1983–2008 versus the new 165 pol sequences collected during 2016–2018 reported in this study. Cpx, complex; CRF, circulating recombinant form; URF, unique recombinant form. *p value < 0.05.

Changes in the HIV-1 molecular epidemiology in the DRC (1976–2018) and in Kinshasa (1983–2018)

In order to analyze the HIV-1 molecular epidemiology evolution over time in the DRC, we compared the current HIV-1 variants in pol circulating in Kinshasa (2016–2018) with the 2588 pol sequences previously reported in the country with known sampling year (1976–2012) and newly reclassified in this study. Globally, a significant reduction (p < 0.05) in the percentage of pure subtypes and simultaneously an increase of URFs (p < 0.05), were observed after comparing both periods, whereas the proportion of CRFs remained similar across both sequence sets (Fig. 3A, B). The evolution of pure subtypes and recombinant forms in the DRC across a three-year period until 2018 is shown in Fig. 3C.

HIV-1 variant distribution varies greatly between provinces and it is not possible to compare the diversity in Kinshasa with that of the whole country. We therefore performed a new analysis using all available pol sequences deposited in LANL recovered from samples collected in Kinshasa after identifying the accession numbers in the corresponding papers, recovering 181 pol sequences from different subjects. We then compared the HIV-1 variant distribution in Kinshasa from the 181 samples collected exclusively in the city during 1983–2008 (94.5% of them sampled during 2007–2008) versus the new 165 pol sequences collected during 2016–2018 in Kinshasa and newly reported in this study. We observed during 2016–2018 a significant increase in subtype A (10.5% vs. 26.7%, p < 0.05) and sub-subtype F1 (0% vs. 4.8%, p < 0.05) and a significant reduction in sub-subtype A1 (11% vs. 0%, p < 0.05) and subtype D (7.7% vs. 2.4%, p < 0.05) compared to variants from Kinshasa circulating from 1983 to 2008, whereas the proportion of CRFs remained similar across both sequence sets (12.1 vs. 13.2%, respectively). We detected CRF47_BF virus for the first time in the country using pol sequences collected after 2016. URF tended to decrease over time (31% vs. 23.6%). The remaining variants remained stable over time (Fig. 3D).

Differences on genetic diversity across pol sequences sets from the DRC

The global genetic diversity across the 2802 LANL pol sequences (1976–2012) versus our 165 pol sequence set under study (2016–2018) reported similar values (0.90 vs. 0.91) (Table 4). However, considering specific HIV-1 variants, LANL set presented higher genetic diversity in pure-subtypes (0.84 vs. 0.76), whereas diversity of CRFs was higher since 2016 (0.78 vs. 0.89). When the genetic diversity was compared into the most recent sequences, according to age group, it was higher in children/adolescents than adults (0.92 vs. 0.88), mainly in URF variants (0.93 vs. 0.80), whereas in CRFs the diversity was higher in adults versus children/adolescents (0.88 vs. 0.50) (Table 4). Figure 4, shows the high genetic diversity over time in pol sequences sampled in the DRC since the 1976 (year of first available pol sequence) to 2018, with some variations by periods of time.

Table 4 Genetic diversity by study groups in HIV-1 pol sequences from the DRC.
Figure 4
figure 4

Temporal trends of genetic diversity across years in HIV-1 pol sequences from the DRC. Bars in blue, available pol sequences from the DRC with known sampling year. LANL database did not include pol sequences from the DRC sampled during 1977–1982, 1986, 1995, 2009, 2010, and 2013–2015.

Discussion

The DRC is known as the origin of HIV-1 pandemic and the epicenter for the selection and spreading of many HIV-1 variants to neighboring countries28. As a consequence of high HIV-1 genetic heterogenicity (probably the highest diversity rate in the world), the accurate phylogenetic reconstructions have not been easy to interpret29. For this reason, our first approach was to reanalyze the available HIV-1 sequences deposited in LAN from the DRC, observing 8.8% of misclassified sequences according to the new reclassification of HIV-1 variants and phylogenetic programs used in this work.

Global geographical patterns in HIV-1 variants distribution are changing over time due to several factors, such as population movements or the dense transmission networks. These factors are contributing to an unpredictable HIV-1 pandemic30,31. Consequently, a continuous and accurate molecular epidemiology surveillance is necessary for increasing our knowledge about the evolving HIV-1 epidemic, especially in those geographical areas with high genetic diversity rate, where multiple HIV-1 variants co-circulate20,32, such as the DRC. In these settings, the selection of new recombinant forms is easier and the viral evolution could be faster than in those regions with low diversity of HIV-133.

Due to the lack of updated data on HIV molecular epidemiology in the DRC, we present the information of 165 pol sequences obtained in adult and paediatric populations, representing the most recent data on circulating HIV-1 subtypes and recombinant forms in Kinshasa ranging 2016–2018. We also compared the temporal trends of HIV-1 variants in the DRC for a 43-years period, based on 281,10,24,28,29,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56 published studies. Sup. Table 1 shows the sampling year, sample type, study population, number of analyzed sequences, coding regions, subtyping method and sequence submission to databases in each 28 published studies characterizing HIV-1 variants in the DRC. Since HIV is prone to recombination during retrotranscription, high levels of recombinant forms after coinfections or superinfections are expected, especially in places with high viral diversity, such as in the DRC24,34. In this scenario HIV-1 can accelerate adaptation to the host, favouring emerging variants with unknown pathogenicity57.

Previous studies have also reported heterogeneous geographic distribution of group M variants across regions in the DRC58, with high prevalence of recombinants. However, HIV recombinant rates in our study and previously reported in the country could be underestimated since most of them were classified by using short partial genome sequences (Sup. Table 1) and not full genomes. Thus, the recombinant rate in the DRC could be even higher if more viral regions are assessed. Although the biological and clinical impact remains to be clarified, there is growing evidence that recombination has played a significant role in the early history of the HIV-1 pandemic and in viral evolution59. We reported the first identification of CRF47_BF in Africa and the DRC, a recombinant variant first described in Spain60. It would also suggest a possible importation of subtype B to the DRC.

This study confirmed subtype A as the most prevalent subtype, which has maintained a high rate of infections in the DRC over the last three decades61, explaining the high rate of URF carrying subtype A fragments circulating in Kinshasa described in the last years. Kinshasa has been proposed as the origin of A, G and F1 subtypes28, common found HIV-1 variants in our series. Although subtype D was associated with faster disease progression13, was also initially emerged in Kinshasa, its prevalence decreased in the city during 2016–2018 compared to previous years. Although a significant increase of subtype C was reported from 1997 to 2002 in Kinshasa38, in other countries close to the DRC62 and worldwide15, we observed a similar prevalence of this variant in Kinshasa comparing the two time periods under study. The reasons for these findings are unknown.

We also found that almost 4 out of 10 variants circulating in Kinshasa during both periods (1983–2008 and 2016–2018) carried recombinant sequences in pol. When CRFs and URFs diversities were analysed according to age of patients, CRFs diversity in pol was higher in adults and URF diversity higher in children/adolescents in the last period. The trends of HIV-1 genetic diversity should be further explored in the coming years, also including other HIV-1 genes. The high misclassification in sub-subtype A and U pol sequences from the DRC deposited in LANL reveals the need for reclassification by phylogeny with updated reference sequence sets and new reported HIV-1 variants.

Phylogenetic approaches and distance-based analysis represent the most common strategy to identify recent transmission networks63, and it could be useful to identify other HIV infected and uninfected persons at highest risk of transmission who could benefit from HIV prevention interventions64. Some reports have demonstrated that genetic distance restrictive thresholds between 0.01 and 0.02 substitutions per site have been more strongly associated with probable transmission partners than traditional epidemiological connections65,66,67, and a distance of 0.015 could serve as a use proxy for epidemiological relatedness in a surveillance setting66. Our study identified that 3 out of 4 transmission clusters were recent (genetic distance thresholds 0.01–0.0265,66,67). We implemented a strategy based on traceability of genetic fragments, to know the potential network among infected people (Sup. Fig. 6). This strategy, “recombination network”, gave us a dense net and probably a more complete view. The recombination network found involving pol sequences from 17 children/adolescents with no epidemiological link according to clinical data confirmed the important role of recombination in an HIV pandemic and the importance of common ancestor identification to understand recombination origin and spread. As the children are overrepresented in this network, we should suspect that this network is even denser.

This study has some limitations that need to be considered. Firstly, samples from 2016–2018 were collected in two reference hospitals in Kinshasa, which cannot be fully representative of the situation in a city and even more at a country-wide level58. However, the inclusion of all pol sequences from LANL collected in the country over more than 4 decades, from the general population and risk groups, provides a good overview of the huge diversity of the country. A second limitation is the length of recovered pol sequences, which differed across samples, complicating bioinformatic analysis. A third limitation is that some reports in the DRC did not submit sequences to databases, and they were not available in LANL (Sup. Table 1). These reported HIV-1 variants could therefore not be reevaluated by new PhyML analysis to be included in the temporal tend analysis of HIV-1 variants. Thus, we encourage the necessity of sequence submission in all HIV epidemiology studies worldwide before publication, and the inclusion of the sampling year in all submitted sequences, absent in 214 (8%) of pol sequences downloaded from LANL in that country. The lack of routine resistance testing during clinical follow-up of HIV-infected subjects in the DRC limits the pol sequences availability in the DRC. Furthermore, the lack of complete epidemiological information from subjects involved in transmission or recombination clusters limits full understanding of a cluster´s origin. Finally, 51.5% of DBS did not yield any viral sequences, possibly due to the low viral load (40–1000 HIV-1 RNA copies/dot) in more than half of specimens and to the low plasma volume in the 2 dots used for HIV-1 RNA extraction, limiting the ability to get positive PCR amplifications of HIV in these samples.

Since none of sequences downloaded form LANL was sampled after 2012, our sequence set was the most recent in the DRC to date and the highest in number of analyzed pol sequences in Kinshasa. Our study reinforces the use of dried blood as a field-friendly, useful, convenient and alternative specimen type to whole blood or plasma in HIV molecular epidemiology surveillance studies in developing countries or settings with limitations as regards the collection, storing, transportation of plasma or when low blood volume is available68. Only 3 of 27 studies reporting variants in the DRC48,50,51 had used DBS for HIV-1 variant characterization (Sup. Table 1). Although two previous studies reported the full HIV-1 genome (including pol) from a vertically infected 12-month-old baby54 or gag sequences from 15 children in Kimpese, rural DRC53, our study presents the most extensive data regarding HIV-infected children and adolescents in the country. The updated high genetic diversity observed in the DRC also represents a real challenge for future vaccine development and for efficiency of antiretroviral treatment, diagnostic and monitoring tests of HIV infection69.

In conclusion, we report the most recent data related to HIV-1 variants circulating in Kinshasa, the geographical origin of the pandemic, and unique and updated information on the temporal trends of HIV-1 subtypes, CRF and URF in the DRC during 43-year period (from 1976 to 2018) and in Kinshasa from 1983–2018 after reclassification of several available LANL sequences using phylogenetic approach. The data provided increase and update the knowledge of HIV molecular epidemiology in the DRC. Active transmission clusters were detected, and a new strategy offers us a more complete view of transmission networks. Of concern is an overrepresentation of children was observed in the recombination network. Continued molecular surveillance will be essential to determine and trace rare unique recombinant forms or emerging strains of HIV in the country.

Material and methods

Sample collection and viral load quantification

From 2016 to 2018, 2 DBS cards were collected from 340 patients under clinical follow up at Monkole and Kalembelembe Hospitals (Kinshasa, DRC), 71 HIV-infected children (0–14 years) and adolescents (15–21 years) and 269 HIV-infected adults (more than 22 years). DBS preparation and viral load quantification was performed using Cobas Ampliprep/Cobas Taqman HIV-1 test v2.0 (Roche) as previously reported50 considering hematocrit70,71.

Amplification and sequencing

For HIV-1 variant characterization, viral RNA was extracted from 2 DBS dots using NucliSENS EeasyMAG automated platform (BioMerieux) or manual High-Pure Viral Nucleic Acid kit (Roche). The encoding regions PR, RT, and/or IN at HIV-1 pol gene were amplified by RT-PCR and nested-PCR using primers designed by WHO72 and ANRS73. PCR amplicons were purified using the Illustra ExoProStar 1-Step (GE Healthcare Life Sciences, Little Chalfont, UK) and sequenced by Macrogen Inc. (Geumchun-gu, Seoul, Korea). Viral sequences included the complete HIV-1 PR (codons 1–99), partial RT (codons 1–335/440) and IN (codons 1–285).

Accession numbers

PR, RT and IN HIV-1 sequences were submitted to GenBank (www.ncbi.nlm.nih.gov/genbank) with the following accession numbers: MH920378-MH920435, MN530990-MN531082, MN998509-MN998523.

Phylogenetic analysis

Nucleotide sequences were translated and aligned using the ClustalW algorithm implemented in MEGA6. For HIV-1 subtype characterization we used sequences available in Los Alamos HIV Sequence Database (LANL: https://www.hiv.lanl.gov), annotated by country of origin and date. Reference sequences from all HIV-1 variants described to date with available sequence were included (groups, subtypes, sub-subtypes, CRFs). One HIV-1 group N sequence was used as an outgroup. Sequences from groups P/O/N were also downloaded to discard non group-M infections. To alleviate the burden of computer-time required to reconstruct large phylogenies fast algorithms, phylogenetic trees (PhyMLtree) were reconstructed by maximum-likelihood (ML) method with RAxML v8.0 (Randomized Axelerated Maximum Likelihood)74 using the general time reversible plus proportion of invariable sites plus gamma distribution parameter (GTR + I + G) evolutionary model. To estimate the bootstrap values on the inferred topology by RAxML, Shimodaira-Hasegawa (SH) test using FastTree program was used (support > 90%)75. Sequences not clustering with any variant were analyzed using Recombination Detection Program (RDP3v4.13)76, identifying the subtypes involved in eventual recombination events and hypothetical recombination breakpoints. To further confirm the detected putative recombination events, new phylogenetic analyses were performed using the sequence fragments assigned to different subtypes according to the proposed breakpoint position(s) defined by RPD3. The topologies obtained with each fragment were compared to SH, expected likelihood weight, and Kishino-Hasegawa tests using the TREE-PUZZLE 5.2 program. In the positive cases, the recombinant sequences were redefined as URFs; otherwise, sequences with a most recent common ancestor to subtypes sub-subtypes A1-A6 or F1-F2 were identified as subtypes A or F, respectively. The remaining cases were appointed as U. Since it was not possible to sequence the same fragment for all sequences, different regions were analyzed separately.

Transmission clusters in our 165 study sequences from Kinshasa (2006–2018) were defined as viral sequences belonging to the same subtype/CRF/URF and grouped into a single and well-supported cluster (monophyletic clade) with 100% bootstrap values. When only partial pol sequences could be recovered from new samples, each available sequence fragment present in all viruses from the cluster was used for analysis separately. In this way, new recombination events were detected. Sequences with different recombination events but sharing some recombinant fragment and common progenitor virus were considered as transmission networks.

Genetic diversity (D = 1 − ∑f2) of HIV variants in the DRC was analyzed over time, a measure of variability that takes into account the frequencies (f) of all variants. For that purpose, all 2802 pol LANL sequences from the DRC were downloaded and reclassified as previously described. Among them, 2588 (92.3%) reported the sampling year, all belonging to the 1976–2012 period. Viral genetic diversity among HIV-infected children and adults with samples collected in Kinshasa between 2016 and 2018 was also calculated. We analyzed the genetic distance (number of base substitutions per site) or the average evolutionary divergence over all sequence pairs by using the Tamura-Nei model 93 (TN93)77, according to previous reports67. The rate variation among sites was modeled with a gamma distribution and analysis was conducted in MEGA6. We identified a recent transmission cluster in pol sequences showing maximum pairwise genetic distance lower than 0.01, according to previous reports65,66,67. TN93 was used because it is the most general nucleotide substitution model for which distances can be estimated directly from counts of nucleotide pairs in aligned sequences.

Ethical aspects

The project was approved by the Human Subjects Review Committees at Monkole Hospital/University of Kinshasa (Kinshasa, DRC), University Hospital Ramón y Cajal (Madrid, Spain) and University of Navarra (Pamplona, Spain). Informed consent of all enrolled adults and of parents or guardians of enrolled children was obtained. All methods were carried out in accordance with relevant guidelines and regulations. Patients’ names were codified at sampling to maintain confidentiality.

Statistical analysis

Differences in prevalence of HIV-1 variants were tested using T-test and p values < 0.05 were considered statistically significant. Descriptive statistical analysis was performed, median and interquartile range (IQR) was also calculated. Statistical analyses were conducted using Prism 6.0 software from GraphPad version 8.0.1 (San Diego, CA, USA).

References

  1. Worobey, M. et al. Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960. Nature 455, 661–664 (2008).

    ADS  CAS  PubMed  PubMed Central  Article  Google Scholar 

  2. UNAIDS. AIDSinfo. https://aidsinfo.unaids.org/.

  3. Barré-Sinoussi, F. et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Rev. Investig. Clin. 56, 126–129 (2004).

    Google Scholar 

  4. Gao, F. et al. Human infection by genetically diverse SIVSM-related HIV-2 in West Africa. Nature 358, 495–499 (1992).

    ADS  CAS  PubMed  Article  Google Scholar 

  5. Gao, F. et al. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 397, 436–441 (1999).

    ADS  CAS  PubMed  Article  Google Scholar 

  6. Simon, J. H. M., Gaddis, N. C., Fouchier, R. A. M. & Malim, M. H. Evidence for a newly discovered cellular anti-HIV-1 phenotype. Nat. Med. 4, 1397–1400 (1998).

    CAS  PubMed  Article  Google Scholar 

  7. Plantier, J. C. et al. A new human immunodeficiency virus derived from gorillas. Nat. Med. 15, 871–872 (2009).

    CAS  PubMed  Article  Google Scholar 

  8. De Leys, R. et al. Isolation and partial characterization of an unusual human immunodeficiency retrovirus from two persons of west-central African origin. J. Virol. 64, 1207–1216 (1990).

    PubMed  PubMed Central  Article  Google Scholar 

  9. Robertson, D. L. HIV-1 nomenclature proposal. Science 288(5463), 55–56 (2000).

    CAS  PubMed  Article  Google Scholar 

  10. Yamaguchi, J. et al. Complete genome sequence of CG-0018a-01 establishes HIV-1 subtype L. J. Acquir. Immune Defic. Syndr. 83(3), 319–322 (2020).

    PubMed  Article  Google Scholar 

  11. Los Alamos HIV Sequence Database. HIV Circulating Recombinant Forms (CRFs). https://www.hiv.lanl.gov/content/sequence/HIV/CRFs/CRFs.html#CRF01.

  12. Faria, N. R. et al. The early spread and epidemic ignition of HIV-1 in human populations. Science 346, 56–61 (2014).

    ADS  CAS  PubMed  PubMed Central  Article  Google Scholar 

  13. Baeten, J. M. et al. HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads. J. Infect. Dis. 195, 1177–1180 (2007).

    PubMed  Article  Google Scholar 

  14. Amornkul, P. N. et al. Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa. AIDS 27, 2775–2786 (2013).

    CAS  PubMed  Article  Google Scholar 

  15. Venner, C. M. et al. Infecting HIV-1 subtype predicts disease progression in women of sub-Saharan Africa. EBioMedicine 13, 305–314 (2016).

    PubMed  PubMed Central  Article  Google Scholar 

  16. Price, M. A. et al. Control of the HIV-1 load varies by viral subtype in a large cohort of African adults with incident HIV-1 infection. J. Infect. Dis. 220, 432–441 (2019).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  17. Alvarez, P. et al. HIV-1 variability and viral load technique could lead to false positive HIV-1 detection and to erroneous viral quantification in infected specimens. J. Infect. 71, 368–376 (2015).

    PubMed  Article  Google Scholar 

  18. Bhargava, M., Cajas, J. M., Wainberg, M. A., Klein, M. B. & Pai, N. P. Do HIV-1 non-B subtypes differentially impact resistance mutations and clinical disease progression in treated populations? Evidence from a systematic review. J. Int. AIDS Soc. 17, 18944 (2014).

    PubMed  PubMed Central  Article  Google Scholar 

  19. Sacktor, N. et al. HIV Subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda. Clin. Infect. Dis. 49, 780–786 (2009).

    PubMed  Article  Google Scholar 

  20. Carr, J. K. Viral diversity as a challenge to HIV-1 vaccine development. Curr. Opin. HIV AIDS 1, 294–300 (2006).

    PubMed  Article  Google Scholar 

  21. Taylor, B. S., Sobieszczyk, M. E., McCutchan, F. E. & Hammer, S. M. The challenge of HIV-1 subtype diversity. N. Engl. J. Med. 358, 1590 (2008).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  22. Tebit, D. M. & Arts, E. J. Tracking a century of global expansion and evolution of HIV to drive understanding and to combat disease. Lancet. Infect. Dis. 11, 45–56 (2011).

    PubMed  Article  Google Scholar 

  23. Junqueira, D. M. & de Matos Almeida, S. E. HIV-1 subtype B: Traces of a pandemic. Virology 495, 173–184 (2016).

    CAS  PubMed  Article  Google Scholar 

  24. Vidal, N. et al. Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) Group M genetic diversity in the democratic republic of congo suggests that the HIV-1 pandemic originated in central Africa. J. Virol. 74, 10498–10507 (2000).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  25. Pineda-Peña, A. C. et al. On the contribution of Angola to the initial spread of HIV-1. Infect. Genet. Evol. 46, 219–222 (2016).

    PubMed  PubMed Central  Article  Google Scholar 

  26. Zhu, T. et al. An African HIV-1 sequence from 1959 and implications for the origin of the epidemic. Nature 391, 594–597 (1998).

    ADS  CAS  PubMed  Article  Google Scholar 

  27. Gryseels, S. et al. A near-full-length HIV-1 genome from 1966 recovered from formalin-fixed paraffin-embedded tissue. Proc. Natl. Acad. Sci. USA 117, 12222–12229 (2020).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  28. Faria, N. R. et al. Distinct rates and patterns of spread of the major HIV-1 subtypes in Central and East Africa. PLoS Pathog. 15, e1007976 (2019).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  29. Rodgers, M. A. et al. Sensitive next-generation sequencing method reveals deep genetic diversity of HIV-1 in the Democratic Republic of the Congo. J. Virol. 91(6), e01841–16 (2017).

    MathSciNet  PubMed  PubMed Central  Article  Google Scholar 

  30. Kamangu, E. N. Implication of neighbors in the genetic diversity of the human immunodeficiency virus type 1 in the Democratic Republic of Congo. ARC J. AIDS 3, 26–28 (2018).

    Google Scholar 

  31. Peeters, M., Mulanga-Kabeya, C. & Delaporte, E. The genetic diversity of HIV-1. Virologie 4(5), 313–320 (2020).

    Google Scholar 

  32. Gaschen, B. et al. Diversity considerations in HIV-1 vaccine selection. Science (80-) 296, 2354–2360 (2002).

    ADS  CAS  Article  Google Scholar 

  33. Hemelaar, J. et al. Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis. Lancet Infect. Dis. 19, 143–155 (2019).

    PubMed  Article  Google Scholar 

  34. Yang, C. et al. Genetic diversification and recombination of HIV type 1 group M in Kinshasa, Democratic Republic of Congo. AIDS Res. Hum. Retroviruses 21, 661–666 (2005).

    CAS  PubMed  Article  Google Scholar 

  35. Yang, C. et al. Predominance of HIV type 1 subtype G among commercial sex workers from Kinshasa, Democratic Republic of Congo. AIDS Res. Hum. Retroviruses 17, 361–365 (2001).

    CAS  PubMed  Article  Google Scholar 

  36. Gao, F. et al.. Molecular characterization of a highly divergent HIV type 1 isolate obtained early in the AIDS epidemic from the Democratic Republic of Congo. AIDS Res. Hum. Retroviruses 17(12), 1217–1222 (2001).

    CAS  PubMed  Article  Google Scholar 

  37. Kita, K. et al. Genetic diversity of HIV type 1 in Likasi, southeast of the Democratic Republic of Congo. AIDS Res. Hum. Retroviruses 20, 1352–1357 (2004).

    CAS  PubMed  Article  Google Scholar 

  38. Vidal, N. et al. Distribution of HIV-1 variants in the Democratic Republic of Congo suggests increase of subtype C in Kinshasa between 1997 and 2002. J. Acquir. Immune Defic. Syndr. 40, 456–462 (2005).

    PubMed  Article  Google Scholar 

  39. Vidal, N. et al. HIV type 1 pol gene diversity and antiretroviral drug resistance mutations in the Democratic Republic of Congo (DRC). AIDS Res. Hum. Retroviruses 22, 202–206 (2006).

    CAS  PubMed  Article  Google Scholar 

  40. Vidal, N. et al. Identification and molecular characterization of subsubtype A4 in Central Africa. AIDS Res. Hum. Retroviruses 22, 182–187 (2006).

    CAS  PubMed  Article  Google Scholar 

  41. Vidal, N. et al. Characterization of an old complex circulating recombinant form, CRF27_cpx, originating from the Democratic Republic of Congo (DRC) and circulating in France. AIDS Res. Hum. Retroviruses 24, 315–321 (2008).

    CAS  PubMed  Article  Google Scholar 

  42. Vidal, N., Bazepeo, S. E., Mulanga, C., Delaporte, E. & Peeters, M. Genetic characterization of eight full-length HIV type 1 genomes from the democratic republic of Congo (DRC) reveal a new subsubtype, A5, in the a radiation that predominates in the recombinant structure of CRF26-A5U. AIDS Res. Hum. Retroviruses 25, 823–832 (2009).

    CAS  PubMed  Article  Google Scholar 

  43. Niama, F. R. et al. CRF45-AKU, a circulating recombinant from central Africa, Is probably the common ancestor of hiv Type 1 MAL and HIV type 1 NOGIL. AIDS Res. Hum. Retroviruses 25, 1345–1353 (2009).

    CAS  PubMed  Article  Google Scholar 

  44. Huang, D. D., Foley, B. T., Tolzmann, C. A., Ouma, A. & Bremer, J. W. Complex mosaic composition of near full-length genomes of two NED (NIH-ENVA-DOD) subtype panel HIV type 1 strains, BCF-Dioum and BCF-Kita, originating from the Democratic Republic of Congo (DRC). AIDS Res. Hum. Retroviruses 25, 1039–1043 (2009).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  45. Djoko, C. F. et al. High HIV type 1 group M pol diversity and low rate of antiretroviral resistance mutations among the uniformed services in Kinshasa, Democratic Republic of the Congo. AIDS Res. Hum. Retroviruses 27, 323–329 (2011).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  46. Muwonga, J. et al. Resistance to antiretroviral drugs in treated and drug-naive patients in the democratic Republic of Congo. J. Acquir. Immune Defic. Syndr. 57(Suppl 1), S27-S33 (2011).

    CAS  PubMed  Article  Google Scholar 

  47. Kamangu, E. et al. Genetic Diversity and Antiretroviral Drug Resistance among Drug-Naïve HIV Type 1 Infected Patients attending Clinics in Kinshasa, Democratic Republic of Congo. J. HIV AIDS 1(1) (2015).

  48. Boillot, F. et al. Implementation and Operational Research: Programmatic Feasibility of Dried Blood Spots for the Virological Follow-up of Patients on Antiretroviral Treatment in Nord Kivu, Democratic Republic of the Congo. J. Acquir. Immune Defic. Syndr. 71, e9–e15 (2016).

    CAS  PubMed  Article  Google Scholar 

  49. Villabona Arenas, C. et al. Divergent HIV-1 strains (CRF92_C2U and CRF93_cpx) co-circulating in the Democratic Republic of the Congo: Phylogenetic insights on the early evolutionary history of subtype C. Virus Evol. 3(2), vex032 (2017).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  50. Rubio-Garrido, M. et al. Utility Of POC Xpert HIV-1 tests for detection-quantification of complex HIV recombinants using dried blood spots from Kinshasa, D. R. Congo. Sci. Rep. 9, 5679 (2019).

    ADS  PubMed  PubMed Central  Article  CAS  Google Scholar 

  51. Kwon, E. H. et al. HIV-1 subtypes and drug resistance mutations among female sex workers varied in different cities and regions of the Democratic Republic of Congo. PLoS ONE 15, e0228670 (2020).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  52. Potts, K. E. et al. Genetic diversity of human immunodeficiency virus type 1 strains in Kinshasa, Zaire. AIDS Res. Hum. Retroviruses 9, 613–618 (1993).

    CAS  PubMed  Article  Google Scholar 

  53. Mokili, J. L. K. et al. Genetic heterogeneity of HIV type 1 subtypes in Kimpese, rural democratic republic of congo. AIDS Res. Hum. Retroviruses 15, 655–664 (1999).

    CAS  PubMed  Article  Google Scholar 

  54. Mokili, J. L. K. et al. Identification of a novel clade of human immunodeficiency virus type 1 in Democratic Republic of Congo. AIDS Res. Hum. Retroviruses 18, 817–823 (2002).

    CAS  PubMed  Article  Google Scholar 

  55. Triques, K. et al. Near-full-length genome sequencing of divergent African HIV type 1 subtype F viruses leads to the identification of a new HIV type 1 subtype designated K. AIDS Res. Hum. Retroviruses 16, 139–151 (2000).

    CAS  PubMed  Article  Google Scholar 

  56. Vidal, N., Mulanga-Kabeya, C., Nzilambi, N., Delaporte, E. & Peeters, M. Identification of a complex env subtype E HIV type 1 virus from the Democratic Republic of Congo, recombinant with A, G, H, J, K, and unknown subtypes. AIDS Res. Hum. Retroviruses 16, 2059–2064 (2000).

    CAS  PubMed  Article  Google Scholar 

  57. Moradigaravand, D. et al. Recombination Accelerates Adaptation on a Large-Scale Empirical Fitness Landscape in HIV-1. PLoS Genet. 10, e1004439 (2014).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  58. Kamangu, E., Kabututu, Z., Mvumbi, L., Kalala, L. R. & Mesia, K. Genetic diversity of human immunodeficiency virus type 1 in the Democratic Republic of Congo: A review of available data. Int. J. Collab. Res. Intern. Med. Public Health 5, 295–309 (2013).

    Google Scholar 

  59. Olabode, A. S. et al. Evidence for a recombinant origin of HIV-1 Group M from genomic variation. Virus Evol. 5, vey039 (2019).

    PubMed  PubMed Central  Article  Google Scholar 

  60. Fernández-García, A. et al. Identification of a new HIV type 1 circulating BF intersubtype recombinant form (CRF47-BF) in Spain. AIDS Res. Hum. Retroviruses 26, 827–832 (2010).

    PubMed  Article  CAS  Google Scholar 

  61. Kamangu, E., Ikolango, B. B. & Ilunga, B. B. Evolution of Subtypes of the Human Immunodeficiency Virus Type 1 in Kinshasa over the Last 30 years: Documentary Review from 1985 to 2015. Mathews J. HIV/AIDS 2, 014 (2017).

    Google Scholar 

  62. Gartner, M. J., Roche, M., Churchill, M. J., Gorry, P. R. & Flynn, J. K. Understanding the mechanisms driving the spread of subtype C HIV-1. EBioMedicine 53, 102682 (2020).

    PubMed  PubMed Central  Article  Google Scholar 

  63. Hassan, A. S., Pybus, O. G., Sanders, E. J., Albert, J. & Esbjörnsson, J. Defining HIV-1 transmission clusters based on sequence data. AIDS 31, 1211–1222 (2017).

    PubMed  Article  Google Scholar 

  64. Van De Vijver, D. A. M. C. & Boucher, C. A. B. Insights on transmission of HIV from phylogenetic analysis to locally optimize HIV prevention strategies. Curr. Opin. HIV AIDS 13, 95–101 (2018).

    PubMed  Article  Google Scholar 

  65. Wertheim, J. O. et al. The global transmission network of HIV-1. J. Infect. Dis. 209, 304–313 (2014).

    PubMed  Article  Google Scholar 

  66. Wertheim, J. O. et al. Social and Genetic Networks of HIV-1 Transmission in New York City. PLoS Pathog. 13, e1006000 (2017).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  67. Kosakovsky Pond, S. L., Weaver, S., Leigh Brown, A. J. & Wertheim, J. O. HIV-TRACE (transmission cluster engine): a tool for large scale molecular epidemiology of HIV-1 and other rapidly evolving pathogens. Mol. Biol. Evol. Evol 35, 1812–1819 (2018).

    Article  CAS  Google Scholar 

  68. De Mulder, M. & Holguín, Á. Utilidad de los dried blood spots para monitorizar la infección por virus de la inmunodeficiencia humana en los programas de salud pública de países en desarrollo. Enferm. Infecc. Microbiol. Clin. 31, 100–107 (2013).

    PubMed  Article  Google Scholar 

  69. Stone, M. et al. Comparison of detection limits of fourth- and fifth-generation combination HIV antigen-antibody, p24 antigen, and viral load assays on diverse HIV isolates. J. Clin. Microbiol. 6(8), e02045-17 (2018).

    Article  Google Scholar 

  70. Robins, E. B. & Blum, S. Hematologic reference values for African American children and adolescents. Am. J. Hematol. 82, 611–614 (2007).

    CAS  PubMed  Article  Google Scholar 

  71. U.S. Food and Drug Administration (FDA). Investigations Operations Manual 2020. https://www.fda.gov/inspections-compliance-enforcement-and- (2020).

  72. World Health Organization (WHO). WHO Manual for HIV Drug Resistance Testing using Dried Blood Specimens. https://www.who.int/hiv/pub/drugresistance/dried_blood_spots/en/ (2010).

  73. National Agency for AIDS Research (ANRS). ANRS AC11 Resistance Study Group PCR and Sequencing Procedures: HIV-1. https://www.hivfrenchresistance.org/ANRS-procedures.pdf (2015).

  74. Stamatakis, A. RAxML version 8: A tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics 30, 1312–1313 (2014).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  75. Price, M. N., Dehal, P. S. & Arkin, A. P. FastTree 2 - Approximately maximum-likelihood trees for large alignments. PLoS ONE 5, e9490 (2010).

    ADS  PubMed  PubMed Central  Article  CAS  Google Scholar 

  76. Martin, D. P. et al. RDP3: A flexible and fast computer program for analyzing recombination. Bioinformatics 26, 2462–2463 (2010).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  77. Tamura, K. & Masatoshi, N. Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees. Mol. Biol. Evol. 10, 512–526 (1993).

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank the patients who participated in the study as well as the local professionals responsible for the DBS and data collection of enrolled patients at Monkole and Kalembelembe hospitals in Kinshasa. We also thank Paul Devlin for his proofreading of the manuscript.

Funding

This study was funded by fundraising activities and donations (mainly of Asociación Bomberos Ayudan), by Instituto de Salud Carlos III through the Projects PI16/01908 and PI18/00904" (Plan Estatal de Investigación Científica y Técnica y de Innovación 2013–2016 and cofinanced by the European Development Regional Fund “A way to achieve Europe”-FEDER and the Government of Navarre (Grant 045-2015). The study was integrated in the research supported by the Spanish HIV infected Paediatric Cohort (CoRISpe) integrated in the Spanish AIDS Research Network and by Instituto de Salud Carlos III, Spanish Health Ministry (Grant nº RD06/0025-ISCIII-FEDER). This study is also included in the “Subprograma de Inmigración y Salud” from CIBERESP (Spain).

Author information

Authors and Affiliations

Authors

Contributions

A.H. and G.R. conceived and designed the study. M.R.G, J.M.G, AH, and J.C.G contributed to data analysis and result discussion. A.H. and S.C. organized in sample shipping. A.N. selected clinical and epidemiological data from patients in DRC and supervised DBS collection and shipping. M.R.G performed the virological analysis of adolescents and paediatric samples and viral sequencing, D.B performed viral amplification and sequencing of adults samples. M.R.G and J.M.G carried out the phylogenetic analysis for variant characterization of the complete study cohort. A.H. and J.C.G supervised phylogenetic analysis. D.B and G.R. performed sequencing and HIV-1 viraemia quantification by Roche assay. A.H, and M.R.G designed final tables and figures and wrote the manuscript. A.N, J.C.G, G.R and S.C revised the paper. All authors approved the final version of manuscript.

Corresponding authors

Correspondence to Gabriel Reina or África Holguín.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Rubio-Garrido, M., González-Alba, J.M., Reina, G. et al. Current and historic HIV-1 molecular epidemiology in paediatric and adult population from Kinshasa in the Democratic Republic of Congo. Sci Rep 10, 18461 (2020). https://doi.org/10.1038/s41598-020-74558-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/s41598-020-74558-z

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing